News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
846,469 Results
Type
Article (86482)
Company Profile (702)
Press Release (759285)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232676)
Career Advice (4127)
Deals (39719)
Drug Delivery (129)
Drug Development (90983)
Employer Resources (198)
FDA (18106)
Job Trends (17334)
News (396452)
Policy (39746)
Tag
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (56833)
ALS (99)
Alzheimer's disease (1503)
Antibody-drug conjugate (ADC) (157)
Approvals (18068)
Artificial intelligence (329)
Autoimmune disease (30)
Automation (16)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (481)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (304)
Cancer (2452)
Cardiovascular disease (206)
Career advice (3534)
Career pathing (34)
CAR-T (174)
Cell therapy (494)
Cervical cancer (21)
Clinical research (73414)
Collaboration (916)
Company closure (1)
Compensation (567)
Complete response letters (30)
COVID-19 (2868)
CRISPR (48)
C-suite (266)
Cystic fibrosis (107)
Data (2284)
Decentralized trials (2)
Denatured (45)
Depression (56)
Diabetes (299)
Diagnostics (6922)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (128)
Drug shortages (33)
Duchenne muscular dystrophy (101)
Earnings (96705)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (130058)
Executive appointments (781)
FDA (19454)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (819)
Gene editing (120)
Generative AI (35)
Gene therapy (359)
GLP-1 (856)
Government (5160)
Grass and pollen (6)
Guidances (75)
Healthcare (20888)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (148)
Indications (30)
Infectious disease (3029)
Inflammatory bowel disease (153)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (101)
Interviews (812)
IPO (17817)
IRA (51)
Job creations (5187)
Job search strategy (2861)
Kidney cancer (11)
Labor market (42)
Layoffs (559)
Leadership (24)
Legal (10113)
Liver cancer (82)
Lung cancer (345)
Lymphoma (159)
Machine learning (7)
Management (65)
Manufacturing (354)
MASH (76)
Medical device (14639)
Medtech (14644)
Mergers & acquisitions (22445)
Metabolic disorders (794)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (115)
Neuropsychiatric disorders (34)
Neuroscience (2111)
NextGen: Class of 2025 (7682)
Non-profit (5082)
Now hiring (40)
Obesity (427)
Opinion (275)
Ovarian cancer (79)
Pain (99)
Pancreatic cancer (88)
Parkinson's disease (161)
Partnered (24)
Patents (251)
Patient recruitment (116)
Peanut (51)
People (65306)
Pharmaceutical (143)
Pharmacy benefit managers (21)
Phase I (22657)
Phase II (31871)
Phase III (24018)
Pipeline (1265)
Policy (173)
Postmarket research (3552)
Preclinical (10223)
Press Release (72)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (430)
Real estate (7392)
Recruiting (75)
Regulatory (26803)
Reports (57)
Research institute (2658)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (81)
Series A (143)
Series B (91)
Service/supplier (30)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4291)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (47)
The Weekly (82)
Vaccines (815)
Venture capitalists (44)
Weight loss (305)
Women's health (40)
Worklife (20)
Date
Today (163)
Last 7 days (930)
Last 30 days (2823)
Last 365 days (35826)
2025 (12008)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (60)
Alaska (7)
Arizona (269)
Arkansas (14)
Asia (50135)
Australia (8831)
California (6488)
Canada (2075)
China (564)
Colorado (284)
Connecticut (303)
Delaware (160)
Europe (114995)
Florida (947)
Georgia (221)
Hawaii (1)
Idaho (64)
Illinois (633)
India (31)
Indiana (337)
Iowa (12)
Japan (171)
Kansas (111)
Kentucky (28)
Louisiana (14)
Maine (70)
Maryland (973)
Massachusetts (4973)
Michigan (249)
Minnesota (424)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (65)
New Hampshire (70)
New Jersey (1835)
New Mexico (31)
New York (1841)
North Carolina (1134)
North Dakota (9)
Northern California (2771)
Ohio (220)
Oklahoma (15)
Oregon (48)
Pennsylvania (1426)
Puerto Rico (13)
Rhode Island (36)
South America (1652)
South Carolina (24)
South Dakota (1)
Southern California (2406)
Tennessee (105)
Texas (973)
United States (24921)
Utah (194)
Virginia (172)
Washington D.C. (71)
Washington State (607)
West Virginia (3)
Wisconsin (70)
There are 846,469 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Inspire Medical Systems, Inc. Announces First Quarter 2025 Financial Results and Updates 2025 Outlook
May 5, 2025
·
13 min read
Press Releases
Coherus to Report First Quarter 2025 Financial Results on May 12, 2025
May 5, 2025
·
2 min read
Press Releases
Syndax Reports First Quarter 2025 Financial Results and Provides Business Update
May 5, 2025
·
17 min read
Press Releases
Editas Medicine to Announce First Quarter 2025 Financial Results and to Participate in Investor Conference in May
May 5, 2025
·
1 min read
Press Releases
Celldex Presents Histology Data from Phase 2 Study of Barzolvolimab in EoE Supporting Potential of Mast Depleting Agent in this Difficult to Treat Disease
May 5, 2025
·
8 min read
Press Releases
Neurocrine Biosciences Reports First Quarter 2025 Financial Results and Reaffirms 2025 Financial Guidance
May 5, 2025
·
16 min read
Press Releases
Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Chamber Trial of Reproxalap and Plans NDA Resubmission
May 5, 2025
·
9 min read
Press Releases
Phanes Therapeutics announces first patient dosed in clinical study of peluntamig in combination with atezolizumab
May 5, 2025
·
2 min read
Press Releases
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET
May 5, 2025
·
1 min read
Press Releases
LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference
May 5, 2025
·
1 min read
1 of 84,647
Next
